Chunlan Pu

机构：Third People's Hospital of Chengdu, Southwest Jiaotong University · ORCID：0000-0003-4892-1979

发表论文 37 篇 · 总被引 673 次 · h-index 16

代表论文

• Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer (2022 · European Journal of Medicinal Chemistry · 被引 45)
• Development of PROTAC degrader probe of CDK4/6 based on DCAF16 (2023 · Bioorganic Chemistry · 被引 40)
• Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer (2023 · European Journal of Medicinal Chemistry · 被引 29)
• Current strategies for improving limitations of proteolysis targeting chimeras (2022 · Chinese Chemical Letters · 被引 29)
• Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation (2024 · Journal of Medicinal Chemistry · 被引 25)
• Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice (2022 · Frontiers in Nutrition · 被引 24)